← All trials
NCT01997203
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2012
- Primary completion
- Apr 1, 2013
- Completion date
- Apr 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 100
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Ain Shams UniversityLead sponsor
- Cairo UniversityOverall official - principal investigator
- Ain Shams UniversitySponsor investigator
- Ain Shams UniversityStudy chair
- Suez Canal UniversityStudy chair
- bny swif universityStudy chair
- Ghazza UniversityStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.